Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Chemomab Therapeutics Ltd ADR (NQ: CMMB ) 1.270 +0.080 (+6.72%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Chemomab Therapeutics Ltd ADR < Previous 1 2 3 4 Next > Chemomab Therapeutics Reveals Data From Mid-Stage Study For Liver Disease Candidate, Stock Plunges On Capital Raise July 25, 2024 Chemomab Therapeutics reports successful Phase 2 SPRING trial results for CM-101 in primary sclerosing cholangitis, showing safety and efficacy. Key findings include significant improvements in liver... Via Benzinga CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q1 2024 May 09, 2024 Chemomab Therapeutics just reported results for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Monday's Intraday Session May 06, 2024 Via Benzinga CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q4 2023 March 07, 2024 Chemomab Therapeutics just reported results for the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session February 22, 2024 Via Benzinga A Preview Of Chemomab Therapeutics's Earnings March 30, 2023 Via Benzinga Earnings Scheduled For March 7, 2024 March 07, 2024 Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session February 21, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session February 20, 2024 Via Benzinga What's Going On With Fibro-Inflammatory Disease Focused Chemomab Therapeutics On Tuesday? February 20, 2024 Chemomab Therapeutics' CM-101 granted new patents in Brazil and Israel, currently in Phase 2 SPRING trial for primary sclerosing cholangitis. Topline data readout expected by mid-2024. Via Benzinga Topics Intellectual Property Exposures Intellectual Property Why M.D.C. Holdings Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket January 18, 2024 Shares of M.D.C. Holdings, Inc. (NYSE: MDC) rose sharply in today’s pre-market trading. Sekisui House, Ltd. and M.D.C. Holdings announced an agreement pursuant to which a wholly-owned subsidiary of... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday January 18, 2024 Pre-market stock movers are a hot topic this morning as we check out all of the winners and losers worth keeping tabs on for Thursday! Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday November 29, 2023 Pre-market stock movers are a good way to start the day as we dive into the biggest news worth checking out on Wednesday morning! Via InvestorPlace Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session November 16, 2023 Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings. Via Benzinga Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket November 16, 2023 Shares of Palo Alto Networks, Inc. (NASDAQ: PANW) fell in pre-market trading after reporting first-quarter results. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday November 16, 2023 It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday! Via InvestorPlace Crude Oil Falls 2%; TJX Issues Weak Earnings Outlook November 15, 2023 U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 150 points on Wednesday. The Dow traded up 0.46% to 34,989.30 while the NASDAQ rose 0.16% to 14,116.28. The S&P... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 15, 2023 Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results. Via Benzinga US Stocks Gain; Producer Prices Fall In October November 15, 2023 U.S. stocks traded higher this morning, with the Dow Jones gaining around 90 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.27% to 34,922.07 while the NASDAQ rose... Via Benzinga Topics Stocks Exposures US Equities Why is Liver Disease Focused Chemomab Stock Trading Higher Today? November 15, 2023 Chemomab Therapeutics Ltd (NASDAQ: CMMB) shares are trading higher after the FDA granted CM-101 Fast Track designation for adult patients of primary sclerosing cholangitis (PSC), Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Wednesday's Pre-Market Session November 15, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023 October 06, 2023 Via Benzinga Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 22, 2023 Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private... Via Benzinga What's Going On With Chemomab Therapeutics Stock Today June 21, 2023 Chemomab Therapeutics Ltd (NASDAQ: CMMB) reported topline results from secondary Phase 2a liver fibrosis trial analyses assessing CM-101 in patients with Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023 June 07, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session February 22, 2023 Via Benzinga Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 21, 2023 Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023. Via Benzinga Why Chemomab Therapeutics Shares Are Trading Higher Today February 21, 2023 Chemomab Therapeutics Ltd (NASDAQ: CMMB) shares are trading higher on Tuesday after the company announced FDA clearance of its Investigational New Drug Application to evaluate CM-101 in a Phase 2 trial... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session February 21, 2023 Via Benzinga Why Is Arrival (ARVL) Stock Up Today? February 21, 2023 Arrival (ARVL) stock is rising higher on Tuesday thanks to news of a $50 million new equity capital commitment and debt reduction. Via InvestorPlace < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.